Equity · Healthcare
IMNM
Immunome, Inc. · NasdaqCM
The line runs $21.20 on 30 June through $22.31 on 17 July, on a scale from $21 to $25. Days the market did not trade hold the previous close, flat.
The chart above plots the price of IMNM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 13 sessions over that window: $21.20 on 30 June 2026 through $22.31 on 17 July 2026.
Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 17, 2026
IMNM insider trades
Showing the 12 most recent of 13 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
IMNM reported financials
IMNM reported revenue of $6.9M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$212.4M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
IMNM earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
IMNM institutional holders
6 of the 45 institutional funds we track reported a IMNM position for the quarter ended 30 Jun 2026 — a combined $22.6M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings
IMNM fails-to-deliver
On 25 Aug 2026, 1,036 shares of IMNM failed to deliver (about $29K) — the latest of 2 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data